Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $3.92 million. The enterprise value is $1.29 million.
Important Dates
The next estimated earnings date is Friday, March 28, 2025, after market close.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 13.71 million shares outstanding. The number of shares has increased by 99.08% in one year.
| Current Share Class | 13.71M |
| Shares Outstanding | 13.71M |
| Shares Change (YoY) | +99.08% |
| Shares Change (QoQ) | +44.14% |
| Owned by Insiders (%) | 16.97% |
| Owned by Institutions (%) | 1.83% |
| Float | 10.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.81 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.93 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -643.28 |
Financial Efficiency
Return on equity (ROE) is -417.05% and return on invested capital (ROIC) is -235.58%.
| Return on Equity (ROE) | -417.05% |
| Return on Assets (ROA) | -190.79% |
| Return on Invested Capital (ROIC) | -235.58% |
| Return on Capital Employed (ROCE) | -649.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.99M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.14% in the last 52 weeks. The beta is 0.38, so Oragenics's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -92.14% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 45.79 |
| Average Volume (20 Days) | 14,286,710 |
Short Selling Information
The latest short interest is 2.13 million, so 15.57% of the outstanding shares have been sold short.
| Short Interest | 2.13M |
| Short Previous Month | 634,588 |
| Short % of Shares Out | 15.57% |
| Short % of Float | 20.23% |
| Short Ratio (days to cover) | 3.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | -13.49M |
| Operating Income | -20.00M |
| Pretax Income | -19.52M |
| Net Income | -19.97M |
| EBITDA | -19.98M |
| EBIT | -20.00M |
| Earnings Per Share (EPS) | -$4.65 |
Full Income StatementBalance Sheet
The company has $3.14 million in cash and $519,392 in debt, giving a net cash position of $2.62 million or $0.19 per share.
| Cash & Cash Equivalents | 3.14M |
| Total Debt | 519,392 |
| Net Cash | 2.62M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 3.08M |
| Book Value Per Share | 0.16 |
| Working Capital | 1.99M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.68M |
| FCF Per Share | -$0.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |